Senior Director, Oncology Licensing & Partnerships

Bayer; Whippany (NJ); On-site; USD 220,000 - 330,000; Full time

Job summary

Bayer in Whippany, NJ seeks a Senior Director, Licensing Officer - Oncology to drive high-value licensing opportunities, acquisitions, and collaborations. The role requires deep oncology science, strong business judgement, and senior-level partnering skills to represent Bayer externally.

The candidate will lead screening, due diligence, and governance activities, managing cross-functional teams and high-stakes negotiations, with travel up to 40% to engage partners and conferences.

Qualifications

• Advanced degree in life sciences or related field.
• Deep Oncology landscape knowledge, including targets, modalities and development.
• Working knowledge of pharmaceutical licensing processes.
• Hands-on transaction experience is a plus.
• Ability to influence executives and travel up to 40%.

Responsibilities

• Lead technical, clinical and commercial assessment of Oncology licensing opportunities.
• Establish and maintain screening processes aligned with Oncology stakeholders.
• Lead due diligence teams to identify risks and mitigation.
• Present assessments to leadership and governance for approval and contracting.
• Participate in or lead transactions including business case development and negotiation.
• Serve as Bayer's external representative to potential partners and conferences.
• Shape BD&L and strategic initiatives across therapeutic areas.

Skills

Cross-functional leadership

Analytical skills

Communication

Presentation skills

Business acumen

Travel up to 40%

Education

PhD/PharmD/MD/MS or equivalent

Job description

Bayer in Whippany, NJ seeks a Senior Director, Licensing Officer - Oncology to drive high-value licensing opportunities, acquisitions, and collaborations. The role requires deep oncology science, strong business judgement, and senior-level partnering skills to represent Bayer externally.

The candidate will lead screening, due diligence, and governance activities, managing cross-functional teams and high-stakes negotiations, with travel up to 40% to engage partners and conferences.